Advances in metabolic engineering of Corynebacterium glutamicum to produce high-value active ingredients for food, feed, human health, and well-being.

Corynebacterium glutamicum extremolytes metabolic engineering plant phenols synthetic biology terpenoids

Journal

Essays in biochemistry
ISSN: 1744-1358
Titre abrégé: Essays Biochem
Pays: England
ID NLM: 0043306

Informations de publication

Date de publication:
26 07 2021
Historique:
received: 14 03 2021
revised: 26 04 2021
accepted: 27 04 2021
pubmed: 8 6 2021
medline: 7 4 2022
entrez: 7 6 2021
Statut: ppublish

Résumé

The soil microbe Corynebacterium glutamicum is a leading workhorse in industrial biotechnology and has become famous for its power to synthetise amino acids and a range of bulk chemicals at high titre and yield. The product portfolio of the microbe is continuously expanding. Moreover, metabolically engineered strains of C. glutamicum produce more than 30 high value active ingredients, including signature molecules of raspberry, savoury, and orange flavours, sun blockers, anti-ageing sugars, and polymers for regenerative medicine. Herein, we highlight recent advances in engineering of the microbe into novel cell factories that overproduce these precious molecules from pioneering proofs-of-concept up to industrial productivity.

Identifiants

pubmed: 34096577
pii: 228945
doi: 10.1042/EBC20200134
pmc: PMC8313993
doi:

Substances chimiques

Amino Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

197-212

Informations de copyright

© 2021 The Author(s).

Auteurs

Sabrina Wolf (S)

Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.

Judith Becker (J)

Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.

Yota Tsuge (Y)

Institute for Frontier Science Initiative, Kanazawa University, Japan.

Hideo Kawaguchi (H)

Graduate School of Science, Technology and Innovation, Kobe University, Japan.

Akihiko Kondo (A)

Graduate School of Science, Technology and Innovation, Kobe University, Japan.
Graduate School of Engineering, Kobe University, Japan.
Biomass Engineering Research Division, RIKEN, Yokohama, Japan.

Jan Marienhagen (J)

Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich, Germany.
Institute of Biotechnology, RWTH Aachen University, Aachen, Germany.
The Bioeconomy Science Center (BioSC), Forschungszentrum Jülich, Germany.

Michael Bott (M)

Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich, Germany.
The Bioeconomy Science Center (BioSC), Forschungszentrum Jülich, Germany.

Volker F Wendisch (VF)

Genetics of Prokaryotes, Biology & CeBiTec, Bielefeld University, Germany.

Christoph Wittmann (C)

Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH